Pharma major Lupin Limited (Lupin) announced the launch of Hydrocortisone Valerate Cream USP, 0.2%, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.
Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of Westcort® Cream, 0.2%, of Sun Pharmaceutical Industries Inc. It is indicated for the relief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.
Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort® Cream) had an annual sales of approximately USD 11.5 million in the U.S. (IQVIA MAT September 2019).
Shares of LUPIN LTD. was last trading in BSE at Rs.773.3 as compared to the previous close of Rs. 770.75. The total number of shares traded during the day was 51963 in over 2396 trades.
The stock hit an intraday high of Rs. 781.65 and intraday low of 767.2. The net turnover during the day was Rs. 40216286.